Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 4 hours 20 min ago

Provention's med for delaying diabetes wins go-ahead for FDA resubmission

Thu, 01/27/2022 - 13:33
Provention's med for delaying diabetes wins go-ahead for FDA resubmission aarmstrong Thu, 01/27/2022 - 16:33

'Up to Paul now': Galapagos' new CEO Stoffels jumps straight into deal talks, finding a new science chief

Thu, 01/27/2022 - 10:08
'Up to Paul now': Galapagos' new CEO Stoffels jumps straight into deal talks, finding a new science chief klahucik Thu, 01/27/2022 - 13:08

InnovHeart opens the funding valve with $55M to usher mitral system through clinical trials

Thu, 01/27/2022 - 08:52
InnovHeart opens the funding valve with $55M to usher mitral system through clinical trials apark Thu, 01/27/2022 - 11:52

BioVentrix snatches up MateraCor for a hydrogel-based approach to heart failure

Thu, 01/27/2022 - 07:18
BioVentrix snatches up MateraCor for a hydrogel-based approach to heart failure chale Thu, 01/27/2022 - 10:18

Philips adds even more ventilators to Class I recall caused by faulty sound-muffling foam

Thu, 01/27/2022 - 07:04
Philips adds even more ventilators to Class I recall caused by faulty sound-muffling foam apark Thu, 01/27/2022 - 10:04

Moderna, Excision each enter HIV battle with mRNA and CRISPR tech

Thu, 01/27/2022 - 06:34
Moderna, Excision each enter HIV battle with mRNA and CRISPR tech klahucik Thu, 01/27/2022 - 09:34

Taysha mulls tweaks to gene therapy trial after subject dies

Thu, 01/27/2022 - 05:45
Taysha mulls tweaks to gene therapy trial after subject dies ntaylor Thu, 01/27/2022 - 08:45

Neck and neck with Pfizer, Moderna gives first dose of omicron-specific booster in phase 2 trial

Thu, 01/27/2022 - 04:23
Neck and neck with Pfizer, Moderna gives first dose of omicron-specific booster in phase 2 trial ntaylor Thu, 01/27/2022 - 07:23

Nine-year J&J science chief Stoffels to steer Galapagos' rebound as CEO

Wed, 01/26/2022 - 13:35
Nine-year J&J science chief Stoffels to steer Galapagos' rebound as CEO klahucik Wed, 01/26/2022 - 16:35

Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder

Wed, 01/26/2022 - 12:34
Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder klahucik Wed, 01/26/2022 - 15:34

With GSK, Alector has the Big Pharma backing to capitalize on a big moment in Alzheimer's drug development

Wed, 01/26/2022 - 11:26
With GSK, Alector has the Big Pharma backing to capitalize on a big moment in Alzheimer's drug development aarmstrong Wed, 01/26/2022 - 14:26

Blockbuster cancer med Keytruda may help flush out dormant HIV, suggesting a new way to treat long-running epidemic

Wed, 01/26/2022 - 09:40
Blockbuster cancer med Keytruda may help flush out dormant HIV, suggesting a new way to treat long-running epidemic klahucik Wed, 01/26/2022 - 12:40

Abbott weathers 2021’s COVID-testing roller coaster ride with $7.7B in annual diagnostic sales

Wed, 01/26/2022 - 08:25
Abbott weathers 2021’s COVID-testing roller coaster ride with $7.7B in annual diagnostic sales apark Wed, 01/26/2022 - 11:25

Sweden's Trialbee buzzes with growth as sales double, partnerships expand

Wed, 01/26/2022 - 07:57
Sweden's Trialbee buzzes with growth as sales double, partnerships expand jkeenan Wed, 01/26/2022 - 10:57

Robotic surgery developer Distalmotion nets $90M to expand to US shores

Wed, 01/26/2022 - 07:23
Robotic surgery developer Distalmotion nets $90M to expand to US shores chale Wed, 01/26/2022 - 10:23

Ziopharm hopes to put a rough year behind it with rebrand to Alaunos Therapeutics

Wed, 01/26/2022 - 07:11
Ziopharm hopes to put a rough year behind it with rebrand to Alaunos Therapeutics klahucik Wed, 01/26/2022 - 10:11

Clarify Health launches software to expand diversity in clinical trials

Wed, 01/26/2022 - 07:08
Clarify Health launches software to expand diversity in clinical trials jkeenan Wed, 01/26/2022 - 10:08

Akili inks $1B SPAC deal to take prescription video game tech public

Wed, 01/26/2022 - 06:51
Akili inks $1B SPAC deal to take prescription video game tech public apark Wed, 01/26/2022 - 09:51

CytoDyn board ousts CEO after a wild year, leaving an albatross of a C-suite job to fill

Wed, 01/26/2022 - 06:44
CytoDyn board ousts CEO after a wild year, leaving an albatross of a C-suite job to fill aarmstrong Wed, 01/26/2022 - 09:44

Cortexyme forced to pivot hopes to 2nd Alzheimer's hopeful after FDA slaps hold on failed effort

Wed, 01/26/2022 - 06:19
Cortexyme forced to pivot hopes to 2nd Alzheimer's hopeful after FDA slaps hold on failed effort klahucik Wed, 01/26/2022 - 09:19